Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)

NCT01914003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2017-11-06

Study results available
· View outcomes & findings →

Summary

Congenital sucrose-isomaltase deficiency (CSID) is a rare, genetic disease in which mutations in the sucrose-isomaltase (SI) gene cause digestion problems of sucrose resulting in diarrhea and abdominal pain. Children with chronic, idiopathic diarrhea or abdominal pain will have their sucrose-isomaltase gene assessed for a panel of known CSID mutations to determine the prevalence of these mutations in an enriched population and also determine functional deficiency using a breath test.

Conditions

  • Congenital Sucrase-isomaltase Deficiency (CSID)

Sponsors & Collaborators

  • Arnold Palmer Hospital for Children

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • Nationwide Children's Hospital

    collaborator OTHER
  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER
  • University of Mississippi Medical Center

    collaborator OTHER
  • Children's Hospital and Research Center at Oakland

    collaborator UNKNOWN
  • Columbia University

    collaborator OTHER
  • Children's Hospital Los Angeles

    collaborator OTHER
  • Children's Hospital and Health System Foundation, Wisconsin

    collaborator OTHER
  • Children's Center for Digestive Healthcare, LLC

    collaborator UNKNOWN
  • Massachusetts General Hospital

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • Children's Hospital of Philadelphia

    collaborator OTHER
  • Children's Mercy Hospital Kansas City

    collaborator OTHER
  • Children's Hospital Colorado

    collaborator OTHER
  • Riley Children's Hospital

    collaborator UNKNOWN
  • Primary Children's Hospital

    collaborator OTHER
  • State University of New York - Downstate Medical Center

    collaborator OTHER
  • QOL Medical, LLC

    lead INDUSTRY

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-05-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01914003 on ClinicalTrials.gov